Clinical use of antimicrobial body washes questioned at CTFA/SDA symposium on HCCM.
This article was originally published in The Rose Sheet
Executive Summary
BODY WASH ANTIMICROBIALS CLINICAL USEFULNESS QUESTIONED BY FDA Division of Anti-infective Drug Products Clinical Reviewer David Bostwick at a June 2-3 symposium on the Healthcare Continuum Model held jointly by the Cosmetic, Toiletry and Fragrance Association and the Soap and Detergent Association. The model, which was submitted to FDA in June 1995, is the industry's answer to regulation of antimicrobial products used by consumers, food handlers and healthcare professionals ("The Rose Sheet" April 3, 1995, p. 1). The proposal responds to the agency's 1994 TFM which set up a regulatory scheme for antimicrobial skin cleanser categories ("The Tan Sheet" June 27, 1994, pp. 7-10).